News
| 4 min read
FDA rejections and safety concerns, a once-monthly HIV PrEP pill, developments in neuroscience drug development, and more led the news this week.
| 4 min read
Explore the link between GLP-1 drugs and cancer. A new study reveals these therapies may reduce the risk of obesity-related cancers, similar to bariatric surgery.
| 4 min read
An injection of an antisense oligonucleotide in utero improved outcomes for mice with the neurogenetic disease.
| 4 min read
A new CRISPR center for kids, Trump threatens 200 percent tariffs on foreign-made drugs, the first malaria treatment for babies, and more led this week’s news.
| 4 min read
Learn about the Teal Wand™, an FDA-approved at-home HPV test from Teal Health. This self-collection test is expanding access to cervical cancer screening.
| 3 min read
To help clinicians monitor slow-healing chronic wounds, researchers created the iCares device and tested it in 20 people with a variety of wounds.
| 4 min read
Two new FDA approvals and promising clinical trial results for drugs to treat diabetes and lung cancer, and more led the news this week.
| 5 min read
From new biomarkers to smarter clinical trials, AI is transforming how cancer drugs are developed and how patients are diagnosed and treated.
| 10+ min read
Using artificial intelligence and machine learning, a team of researchers engineered an enzyme to degrade toxic PFAS molecules — and they’re only in high school.
| 3 min read
Boosting UBA5 gene production normalized neuronal activity in the first organoid model of the developmental and epileptic encephalopathy.
| 3 min read
A blood test for organ rejection, another death related to gene therapy for Duchenne muscular dystrophy, a setback for AbbVie, and more led the news this week.
| 8 min read
Explore how suprachoroidal injection is a groundbreaking new macular degeneration treatment. Learn how it offers a safer, more targeted alternative to a traditional subretinal injection.
